MaxCyte (LON:MXCT) Hits New 1-Year Low – Here’s What Happened

by · The Cerbat Gem

MaxCyte, Inc. (LON:MXCT – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 182 ($2.38) and last traded at GBX 183 ($2.40), with a volume of 82541 shares trading hands. The stock had previously closed at GBX 197 ($2.58).

MaxCyte Trading Down 1.0 %

The company has a debt-to-equity ratio of 8.59, a quick ratio of 14.38 and a current ratio of 9.81. The firm has a market capitalization of £250.81 million, a P/E ratio of -6.96 and a beta of 1.13. The firm has a 50 day simple moving average of GBX 265.15 and a two-hundred day simple moving average of GBX 296.21.

MaxCyte Company Profile

(Get Free Report)

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.

Featured Stories